Baseline lymphocyte to monocyte ratio (LMR) and systemic inflammation index (SII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: Preliminary results of the Meet-URO 15 (I-BIO-REC) study.
暂无分享，去创建一个
G. Banna | S. Buti | A. Cortellini | F. Massari | D. Santini | A. Signori | U. Giorgi | G. Procopio | M. Stellato | M. Messina | M. G. Vitale | V. Martelli | S. E. Rebuzzi | G. Fornarini | V. Mollica | A. Cavo | A. Sbrana | H. Lipari | F. Catalano | M. Sorarù